Ishiguro Hiroki, Walther Donna, Arinami Tadao, Uhl George R
Molecular Neurobiology Branch, NIH-IRP, NIDA, DHHS, Baltimore, MD, USA.
Addiction. 2007 Aug;102(8):1320-5. doi: 10.1111/j.1360-0443.2007.01877.x.
Classical genetic studies consistently reveal substantial heritability for addictions. However, the genes that harbour the variations providing these genetic influences remain largely unknown. We have focused attention on 'reproducible substance abuse vulnerability' (rSA) genomic regions, where linkage and association studies performed in several population provide evidence for such variations.
We nominated rSA1 on human chromosome 3p23 within a 5 Mb region. We sought to replicate this finding and identify variations within this region.
We examine the role of allelic variations in the SLC4A7 gene, a member of the bicarbonate co-transporter family that is expressed in tissues including brain and kidney.
A total of 1158 unrelated individuals with informed consent about the genetic study were recruited from three independent populations.
The single nucleotide polymorphism (SNP) markers in the SLC4A7 gene were analysed by case-control study.
The rs3278 is associated reliably with substance abuse vulnerability in (1) a European American sample selected from pedigrees within the Collaborative Study on the Genetics of Alcoholism (COGA; nominal P = 0.03); (2) an African American sample recruited by the National Institute on Drug Abuse (NIDA; nominal P = 0.008); and (3) a NIDA European American sample (P = 0.001).
While the current results do not exclude additional roles for allelic variants in nearby genes, they do suggest that SLC4A7 allelic variants might alter dispositions and/or excretion of drugs and neurotransmitters in brain and periphery in ways that could contribute to differential vulnerabilities to addictions. SLC4A7 is thus a novel candidate in the contribution to vulnerability to addictions.
经典遗传学研究一直表明成瘾具有显著的遗传性。然而,携带产生这些遗传影响的变异的基因在很大程度上仍然未知。我们将注意力集中在“可重复的药物滥用易感性”(rSA)基因组区域,在多个群体中进行的连锁和关联研究为这种变异提供了证据。
我们在人类3号染色体p23区域的5 Mb范围内指定了rSA1。我们试图重复这一发现并确定该区域内的变异。
我们研究了SLC4A7基因中等位基因变异的作用,SLC4A7基因是碳酸氢盐共转运体家族的成员,在包括脑和肾在内的组织中表达。
从三个独立群体中招募了总共1158名对基因研究知情同意的无亲属关系个体。
通过病例对照研究分析SLC4A7基因中的单核苷酸多态性(SNP)标记。
rs3278与药物滥用易感性可靠相关,(1)从酒精中毒遗传学合作研究(COGA)中的家系中选取的欧裔美国人样本(名义P = 0.03);(2)美国国立药物滥用研究所(NIDA)招募的非裔美国人样本(名义P = 0.008);以及(3)NIDA的欧裔美国人样本(P = 0.001)。
虽然目前的结果不排除附近基因中等位基因变异的其他作用,但它们确实表明SLC4A7等位基因变异可能以有助于导致成瘾易感性差异的方式改变大脑和外周中药物和神经递质的处置和/或排泄。因此,SLC4A7是成瘾易感性研究中的一个新候选基因。